Sklamberg Quoted in The Pink Sheet on Acting FDA Commissioner
Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in an article from The Pink Sheet, "Woodcock To Be Acting US FDA Commissioner, Leaving Agency in Stable, Capable Hands." The article discusses the selection of Janet Woodcock as interim commissioner of the US Food and Drug Administration following the inauguration of President-elect Biden. Sklamberg, a former FDA deputy commissioner for global regulatory operations, notes that Woodcock's technical and operational experience will well serve FDA.
» Read the full article (subscription required).